Filter Results:
(1,274)
Show Results For
- All HBS Web
(1,274)
- People (4)
- News (228)
- Research (897)
- Events (4)
- Multimedia (7)
- Faculty Publications (489)
Show Results For
- All HBS Web
(1,274)
- People (4)
- News (228)
- Research (897)
- Events (4)
- Multimedia (7)
- Faculty Publications (489)
- 18 Apr 2023
- Research & Ideas
The Best Person to Lead Your Company Doesn't Work There—Yet
within their own ranks. “What you really do need is knowledge of that specific industry, whether it's pharmaceutical or manufacturing or hospitality or rocket science.” The findings suggest an active market for CEOs, who are lured to... View Details
- May 2020 (Revised January 2022)
- Case
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (A)
By: Linda A. Hill, Allison J. Wigen and Emily Tedards
Michael Ku joined Pfizer in 2011, after the company had undergone three large-scale mergers and acquisitions. His mission was to drive the digital transformation of the company’s clinical supply chain, but he knew he had to start with the culture. Over the next eight... View Details
Keywords: Innovation; Digital; Change; Culture; Management; Talent; Pharmaceutical Companies; Customer-centricity; Collaboration; Cross-functional Management; Purpose; Leadership; Innovation and Invention; Transformation; Organizational Culture; Change Management; Talent and Talent Management; Customer Focus and Relationships; Supply Chain; Decision Making; Mission and Purpose
Hill, Linda A., Allison J. Wigen, and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (A)." Harvard Business School Case 420-108, May 2020. (Revised January 2022.)
- April 2023 (Revised January 2024)
- Background Note
Note on Healthcare in Ghana
By: Regina E. Herzlinger and Ben Creo
This note provides an overview of the healthcare system in Ghana. It discusses the public and private sector as well as traditional medical practice. It also discusses the country’s pharmaceutical industry. It is recommended as a companion to Professor Regina... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Business and Government Relations; Pharmaceutical Industry; Pharmaceutical Industry; Ghana
Herzlinger, Regina E., and Ben Creo. "Note on Healthcare in Ghana." Harvard Business School Background Note 323-112, April 2023. (Revised January 2024.)
- 26 Oct 2021
- Research & Ideas
What Companies Want Most in a CEO: A Good Listener
For a better shot at landing the top job at today’s companies, aspiring CEOs should set aside their slide presentations and work on their listening skills instead, new research suggests. Companies are increasingly seeking socially adept... View Details
Keywords: by Jay Fitzgerald
- January 2013
- Case
Zappos.com 2009: Clothing, Customer Service, and Company Culture (MM)
By: Frances X. Frei and Robin J. Ely
On July 17, 2009, Zappos.com, a privately-held online retailer of shoes, clothing, and other soft-line retail categories, learned that Amazon.com, a $19 billion multinational online retailer, had won its Board of Directors' approval to offer to merge the two companies.... View Details
Keywords: Customer Relationship Management; Internet and the Web; Mergers and Acquisitions; Organizational Culture; Growth and Development Strategy; Apparel and Accessories Industry; Retail Industry
Frei, Frances X., and Robin J. Ely. "Zappos.com 2009: Clothing, Customer Service, and Company Culture (MM)." Harvard Business School Multimedia/Video Case 612-701, January 2013.
- 01 Feb 2022
- Book
Innovation Isn’t Just for Startups: How Big Companies Can Succeed
What if more managers at big corporations channeled some of the same magic that helped Tesla CEO Elon Musk and Amazon founder Jeff Bezos lead their startups to great success? Large companies are actually fertile ground for innovation;... View Details
Keywords: by Lane Lambert
- 2019
- Article
Industrie-Holding: Creating a Community of Interest among Swiss 'Multinationals'
By: Sabine Pitteloud
This article focuses on the genesis and evolution of Industrie-Holding, a federation of Swiss multinationals, from 1942 onwards. Thanks to recent donations from the Alusuisse and Hero archives, historians now have access to the minutes of the Industrie-Holding... View Details
Keywords: Business ＆ Government Relations; Multinationals; Lobbying; Business and Government Relations; Multinational Firms and Management; Switzerland
Pitteloud, Sabine. "Industrie-Holding: Creating a Community of Interest among Swiss 'Multinationals'." Schweizerische Zeitschrift für Geschichte = Revue suisse d'histoire 69, no. 3 (2019).
- 14 Dec 2010
- Op-Ed
Tax US Companies to Spur Spending
holdings--estimates of the amount held by US public corporations easily exceed $1 trillion; several technology companies alone are sitting on cash balances in excess of $20 billion--are thought to result from the absence of investment... View Details
Keywords: by Mihir A. Desai
- June 2004
- Case
Aventis SA (B): A Company is Born
By: Joshua D. Margolis and Carin-Isabel Knoop
Supplements the (A) case. View Details
Keywords: Problems and Challenges; Mergers and Acquisitions; Horizontal Integration; Organizational Design; Organizational Culture; Pharmaceutical Industry; United States
Margolis, Joshua D., and Carin-Isabel Knoop. "Aventis SA (B): A Company is Born." Harvard Business School Case 404-108, June 2004.
- Teaching Interest
Why is There No Cure for Health Care?
Teaching Fellow for Professor David Cutler - Harvard College Course EMREAS 20
View Details- 26 Jan 2004
- Research & Ideas
What Developing-World Companies Teach Us About Innovation
When most people think of innovation, they envision developed-world companies such as the U.S.A.'s IBM, Japan's Sony, South Korea's Samsung, Finland's Nokia, or Switzerland's Novartis, technology leaders that have stayed at the cutting... View Details
- May 2015
- Case
Transforming Alkermes into a Global Biopharmaceutical Company
By: C. Fritz Foley and Nicholas Haas
In the summer of 2011, Jim Frates, CFO of Alkermes faced choices about how to finance the acquisition of Dublin, Ireland-based Elan Drug Technologies (EDT)—a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information... View Details
Keywords: Financing; Debt; Merger; CFO; Financial Management; Pharmaceutical Industry; Pharmaceutical Industry; United States; Europe
Foley, C. Fritz, and Nicholas Haas. "Transforming Alkermes into a Global Biopharmaceutical Company." Harvard Business School Case 215-079, May 2015.
- 01 Mar 2007
- News
Pharma Suits a Farm Gal
GRAHAM: From rodeo to CEO. Amylin Pharmaceuticals CEO Ginger Graham (MBA ’86) had a good year in 2006, with Amylin stock up as much as 45 percent, with Byetta and Symlin, its two innovative diabetes drugs, performing well, and with the... View Details
- February 2019 (Revised July 2019)
- Case
Sales Force Management at Nobel Ilac
By: Doug J. Chung and Gamze Yucaoglu
Nobel Ilac was a Turkish generic pharmaceutical company marketing more than 100 drugs in 20 countries and, as of 2017, had over 2,500 employees worldwide. Nobel had implemented a transformation strategy—more specifically, a customer segmentation plan—whereby the sales... View Details
Keywords: Sales Strategy; Compensation; Employee Retention; Recruiting; Pharmaceuticals; Salesforce Management; Strategy; Organizational Design; Human Resources; Compensation and Benefits; Employees; Retention; Recruitment; Pharmaceutical Industry; Turkey
Chung, Doug J., and Gamze Yucaoglu. "Sales Force Management at Nobel Ilac." Harvard Business School Case 519-067, February 2019. (Revised July 2019.)
- April 2017
- Case
Imprimis (A)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in... View Details
Keywords: Strategy; Healthcare; Drug Compounding; Pharmaceuticals; Compounding; Drug Development; Decision-making; Mark Baum; Imprimis; Small Business; Decisions; Cost vs Benefits; Business Strategy; Business Model; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (A)." Harvard Business School Case 717-426, April 2017.
- 1986
- Chapter
Competition Encountered by U.S. Companies That Manufacture Abroad
By: Robert B. Stobaugh
- Fall 2019
- Article
Du « défi américain » à l’expansion européenne: Les relations économiques transatlantiques des années cinquante aux années soixante-dix
By: Grace A. Ballor
Economic histories of post-war transatlantic relations have focused on two predominant narratives: US aid for European reconstruction through the Marshall Plan, and the threat of American business investment in Europe. But little research has linked these two elements.... View Details
Keywords: Multinational Corporations; Economic History; International Relations; Business History; Foreign Direct Investment; Multinational Firms and Management
Ballor, Grace A. "Du « défi américain » à l’expansion européenne: Les relations économiques transatlantiques des années cinquante aux années soixante-dix." Relations internationales 180, no. 4 (Fall 2019): 43–57.
- October 2014 (Revised April 2023)
- Case
Gilead: Hepatitis C Access Strategy (A)
By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Pharmaceutical Industry; Pharmaceutical Industry
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
- 24 Nov 2014
- Research & Ideas
Corrupting Silence: Companies Must Speak Up Against Bribes
the cost of investment in developing countries by at least 20 percent. And yet, companies are mostly silent on the subject. "The thing that struck me is how little information there is on corruption because no one wants to talk about it,"... View Details
Keywords: by Michael Blanding
- January 2016 (Revised May 2016)
- Case
IKEA in Saudi Arabia (A)
By: Karthik Ramanna, Jérôme Lenhardt and Marc Homsy
A Swedish newspaper reveals that IKEA has erased all images of women from its catalog for Saudi Arabia. The article sparks criticism of IKEA from the Swedish government and its customers in the West. Critics contend that IKEA is not living up to its own commitments to... View Details
Keywords: Corporate Values; Islam; Multinationals; Globalization; Leadership; Equality and Inequality; Multinational Firms and Management; Religion; Organizational Culture; Gender; Consumer Products Industry; Saudi Arabia; Sweden
Ramanna, Karthik, Jérôme Lenhardt, and Marc Homsy. "IKEA in Saudi Arabia (A)." Harvard Business School Case 116-015, January 2016. (Revised May 2016.)